Education
About Us
Working with TipRanks
Follow Us
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
BLCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.45 - $21.69
Previous CloseN/A
Volume107.99K
Average Volume (3M)1.00M
Market Cap
$4.83B
Enterprise Value$9.36B
Total Cash (Recent Filing)$272.00M
Total Debt (Recent Filing)$4.96B
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Oct 29, 2025EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding353,865,780
10 Day Avg. Volume1,449,315
30 Day Avg. Volume1,000,248
Financial Highlights & Ratios
PEG Ratio-0.93
Price to Book (P/B)0.98
Price to Sales (P/S)1.33
P/FCF Ratio-107.69
Enterprise Value/Market Cap1.94
Enterprise Value/Revenue1.91
Enterprise Value/Gross Profit3.21
Enterprise Value/Ebitda26.66
Forecast
1Y Price Target
$14.50Price Target Upside6.30% Upside
Rating ConsensusHold
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBausch + Lomb reported total revenue of $1,278M, representing a 5.1% year-over-year growth, beating the analyst's projection.
Growth DriversMiebo sales were a key growth driver, contributing significantly to overall BLCO growth with strong optimism for continued growth.
Revenue GuidanceManagement has raised 2025 revenue guidance to $5,050-5,150M, corresponding to 5-7% constant currency growth.
Bears Say
CompetitionMiebo and Xiidra together saw a slight decline in their dry eye new prescription share in May, which could indicate increasing competition in the market.
Market UncertaintyInvestor interest will be limited until there is more visibility on the separation from Bausch Health.
Pricing PressureXIIDRA faced gross-to-net pricing pressure, which is believed to persist through the remainder of 2025.
Bausch + Lomb Corporation News
BLCO FAQ
What was Bausch + Lomb Corporation’s price range in the past 12 months?
Bausch + Lomb Corporation lowest stock price was $10.45 and its highest was $21.69 in the past 12 months.
What is Bausch + Lomb Corporation’s market cap?
Bausch + Lomb Corporation’s market cap is $4.83B.
When is Bausch + Lomb Corporation’s upcoming earnings report date?
Bausch + Lomb Corporation’s upcoming earnings report date is Oct 29, 2025 which is in 80 days.
How were Bausch + Lomb Corporation’s earnings last quarter?
Bausch + Lomb Corporation released its earnings results on Jul 30, 2025. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.062 by $0.008.
Is Bausch + Lomb Corporation overvalued?
According to Wall Street analysts Bausch + Lomb Corporation’s price is currently Undervalued.
Does Bausch + Lomb Corporation pay dividends?
Bausch + Lomb Corporation does not currently pay dividends.
What is Bausch + Lomb Corporation’s EPS estimate?
Bausch + Lomb Corporation’s EPS estimate is 0.16.
How many shares outstanding does Bausch + Lomb Corporation have?
Bausch + Lomb Corporation has 353,865,780 shares outstanding.
What happened to Bausch + Lomb Corporation’s price movement after its last earnings report?
Bausch + Lomb Corporation reported an EPS of $0.07 in its last earnings report, beating expectations of $0.062. Following the earnings report the stock price went down -6.416%.
Which hedge fund is a major shareholder of Bausch + Lomb Corporation?
Currently, no hedge funds are holding shares in BLCO
Bausch + Lomb Corporation Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.50 (6.30% Upside)
$14.50 (6.30% Upside)
Blogger Sentiment
Bullish
BLCO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $247.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.3%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.94%
12-Months-Change
Fundamentals
Return on Equity
-4.22%
Trailing 12-Months
Asset Growth
4.39%
Trailing 12-Months
Company Description
Bausch + Lomb Corporation
Bausch + Lomb Corporation (BLCO) is a leading global eye health company that focuses on the development, manufacturing, and marketing of a wide range of products. The company's core product categories include contact lenses, lens care products, ophthalmic pharmaceuticals, and surgical devices and instruments. Serving both the consumer and the healthcare professional markets, Bausch + Lomb operates in sectors such as Vision Care, Pharmaceuticals, and Surgical, providing solutions aimed at improving vision and overall eye health.
BLCO Company Deck
BLCO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong performance in the Vision Care and Dry Eye segments, with significant growth in contact lenses and dry eye products. The company raised its financial guidance based on these results and successfully refinanced its debt. However, challenges remain with the enVista recall and a decline in the U.S. Generics business impacting overall performance.View all BLCO earnings summariesBLCO Stock 12 Month Forecast
Average Price Target
$14.50
▲(6.30% Upside)
Technical Analysis
Ownership Overview
0.58% Insiders
0.73% Mutual Funds
<0.01% Other Institutional Investors
98.62% Public Companies and
Individual Investors